HUP0202753A3 - Pharmaceutical compositions containing novel combination of loteprednol and b2-adrenoceptor agonists and their use - Google Patents
Pharmaceutical compositions containing novel combination of loteprednol and b2-adrenoceptor agonists and their useInfo
- Publication number
- HUP0202753A3 HUP0202753A3 HU0202753A HUP0202753A HUP0202753A3 HU P0202753 A3 HUP0202753 A3 HU P0202753A3 HU 0202753 A HU0202753 A HU 0202753A HU P0202753 A HUP0202753 A HU P0202753A HU P0202753 A3 HUP0202753 A3 HU P0202753A3
- Authority
- HU
- Hungary
- Prior art keywords
- loteprednol
- pharmaceutical compositions
- compositions containing
- novel combination
- adrenoceptor agonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 title 1
- 229960001798 loteprednol Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19947235A DE19947235A1 (de) | 1999-09-30 | 1999-09-30 | Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten |
| PCT/EP2000/009392 WO2001022956A2 (de) | 1999-09-30 | 2000-09-26 | NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202753A2 HUP0202753A2 (hu) | 2002-12-28 |
| HUP0202753A3 true HUP0202753A3 (en) | 2004-06-28 |
Family
ID=7924101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202753A HUP0202753A3 (en) | 1999-09-30 | 2000-09-26 | Pharmaceutical compositions containing novel combination of loteprednol and b2-adrenoceptor agonists and their use |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7521438B1 (hu) |
| EP (1) | EP1216047B1 (hu) |
| JP (1) | JP5068912B2 (hu) |
| AR (1) | AR025924A1 (hu) |
| AT (1) | ATE306271T1 (hu) |
| AU (1) | AU7907400A (hu) |
| BR (1) | BR0014374B1 (hu) |
| CA (1) | CA2389111C (hu) |
| CY (1) | CY1105548T1 (hu) |
| CZ (1) | CZ296396B6 (hu) |
| DE (2) | DE19947235A1 (hu) |
| DK (1) | DK1216047T3 (hu) |
| EE (1) | EE05050B1 (hu) |
| ES (1) | ES2248131T3 (hu) |
| HU (1) | HUP0202753A3 (hu) |
| MX (1) | MXPA02003329A (hu) |
| PL (1) | PL196729B1 (hu) |
| SI (1) | SI1216047T1 (hu) |
| TW (1) | TWI253930B (hu) |
| WO (1) | WO2001022956A2 (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US20090246281A1 (en) * | 2003-11-03 | 2009-10-01 | Norton Healthcare Ltd. | Soft steroid compositions for use in dry powder inhalers |
| EP2221048A1 (en) | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmaceutical composition for inhalation |
| US9238144B2 (en) * | 2013-03-14 | 2016-01-19 | Neuropace, Inc. | Optimizing data retrieval from an active implantable medical device |
| WO2022016150A1 (en) * | 2020-07-17 | 2022-01-20 | Ross Peter M | Methods for the treatment of cytokine release syndromes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB416950A (en) * | 1933-07-28 | 1934-09-25 | Ambrose Heal | An improved support member for beds, settees, wardrobes and other articles of furniture |
| US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
| ZA814440B (en) * | 1980-07-10 | 1982-10-27 | Otsuka Pharma Co Ltd | Soft steroids having anti-inflammatory activity |
| US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
| TW503113B (en) * | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
| US6461591B1 (en) * | 1997-02-05 | 2002-10-08 | Jago Research Ag | Medical aerosol formulations |
| US5830490A (en) | 1997-04-04 | 1998-11-03 | Weinstein; Robert E. | Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders |
| CN1150895C (zh) | 1998-11-13 | 2004-05-26 | 杰格研究股份公司 | 用于吸入给药的干粉 |
-
1999
- 1999-09-30 DE DE19947235A patent/DE19947235A1/de not_active Withdrawn
-
2000
- 2000-09-26 PL PL353487A patent/PL196729B1/pl not_active IP Right Cessation
- 2000-09-26 EE EEP200200163A patent/EE05050B1/xx not_active IP Right Cessation
- 2000-09-26 AU AU79074/00A patent/AU7907400A/en not_active Abandoned
- 2000-09-26 DE DE50011340T patent/DE50011340D1/de not_active Expired - Lifetime
- 2000-09-26 SI SI200030769T patent/SI1216047T1/sl unknown
- 2000-09-26 JP JP2001526168A patent/JP5068912B2/ja not_active Expired - Fee Related
- 2000-09-26 AT AT00969304T patent/ATE306271T1/de active
- 2000-09-26 HU HU0202753A patent/HUP0202753A3/hu unknown
- 2000-09-26 CZ CZ20021095A patent/CZ296396B6/cs not_active IP Right Cessation
- 2000-09-26 MX MXPA02003329A patent/MXPA02003329A/es active IP Right Grant
- 2000-09-26 ES ES00969304T patent/ES2248131T3/es not_active Expired - Lifetime
- 2000-09-26 WO PCT/EP2000/009392 patent/WO2001022956A2/de not_active Ceased
- 2000-09-26 TW TW089119863A patent/TWI253930B/zh not_active IP Right Cessation
- 2000-09-26 DK DK00969304T patent/DK1216047T3/da active
- 2000-09-26 CA CA002389111A patent/CA2389111C/en not_active Expired - Lifetime
- 2000-09-26 US US10/089,449 patent/US7521438B1/en not_active Expired - Fee Related
- 2000-09-26 EP EP00969304A patent/EP1216047B1/de not_active Expired - Lifetime
- 2000-09-26 BR BRPI0014374-0A patent/BR0014374B1/pt not_active IP Right Cessation
- 2000-09-29 AR ARP000105167A patent/AR025924A1/es not_active Application Discontinuation
-
2005
- 2005-12-15 CY CY20051101559T patent/CY1105548T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2248131T3 (es) | 2006-03-16 |
| PL353487A1 (en) | 2003-11-17 |
| TWI253930B (en) | 2006-05-01 |
| JP2003510276A (ja) | 2003-03-18 |
| BR0014374B1 (pt) | 2012-12-25 |
| AU7907400A (en) | 2001-04-30 |
| MXPA02003329A (es) | 2004-09-10 |
| HUP0202753A2 (hu) | 2002-12-28 |
| EE200200163A (et) | 2003-04-15 |
| WO2001022956A3 (de) | 2001-10-11 |
| EE05050B1 (et) | 2008-08-15 |
| DK1216047T3 (da) | 2006-02-13 |
| ATE306271T1 (de) | 2005-10-15 |
| CA2389111A1 (en) | 2001-04-05 |
| CY1105548T1 (el) | 2010-07-28 |
| US7521438B1 (en) | 2009-04-21 |
| CA2389111C (en) | 2009-04-14 |
| SI1216047T1 (sl) | 2006-02-28 |
| EP1216047B1 (de) | 2005-10-12 |
| DE50011340D1 (de) | 2006-02-23 |
| PL196729B1 (pl) | 2008-01-31 |
| CZ296396B6 (cs) | 2006-03-15 |
| EP1216047A2 (de) | 2002-06-26 |
| BR0014374A (pt) | 2002-06-25 |
| JP5068912B2 (ja) | 2012-11-07 |
| WO2001022956A2 (de) | 2001-04-05 |
| CZ20021095A3 (cs) | 2002-08-14 |
| AR025924A1 (es) | 2002-12-18 |
| DE19947235A1 (de) | 2001-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203971A3 (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use | |
| HUP0103874A3 (en) | Use of antibiotics and pharmaceutical compositions comprising thereof | |
| HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
| HUP0203638A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use | |
| HUP0203895A3 (en) | Substituted azaindoles and pharmaceutical compositions containing them and their use | |
| HUP0200831A3 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
| HUP0101999A3 (en) | 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them | |
| HUP0203556A3 (en) | Pharmaceutical compositions containing oxcarbazepine and their use | |
| HUP0202862A3 (en) | Pharmaceutical composition containing novel combination of loteprednol and antihistamines | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
| HU9901570D0 (en) | Use of nanodispersions in pharmaceutical compositions | |
| IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
| HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0400052A3 (en) | Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use | |
| IL138453A0 (en) | Peptide compositions and formulations and use of same | |
| HUP0103575A3 (en) | Inhibitors of caspases, pharmaceutical compositions comprising thereof and their use | |
| HUP0203575A3 (en) | Pharmaceutical compositions containing th2 differentiation inhibitors and their use | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| HUP0101960A3 (en) | Metabolites of ecteinascidin 743, their use and pharmaceutical compositions containing them | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| HUP0203121A3 (en) | Pharmaceutical composition containing substituted benzimidazoles and its use | |
| AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC9A | Change of name, address |
Owner name: MEDA PHARMA GMBH & CO. KG, DE Free format text: FORMER OWNER(S): VIATRIS GMBH & CO. KG, DE; VIATRIS GMBH & CO. KG, DE |
|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |